![]() |
市场调查报告书
商品编码
1675711
RFID 血液冰箱和冷冻柜市场报告,按类型(RFID 冰箱、RFID 冷冻柜)、应用(医院和诊断中心、血库等)和地区划分,2025 年至 2033 年RFID Blood Refrigerators and Freezers Market Report by Types (RFID Refrigerators, RFID Freezers), Applications (Hospitals and Diagnostic Centers, Blood Banks, and Others), and Region 2025-2033 |
2024 年,全球 RFID 血液冰箱和冷冻机市场规模达到 3.319 亿美元。 展望未来, IMARC Group预计到 2033 年市场规模将达到 10.699 亿美元,2025-2033 年期间的成长率 (CAGR) 为 13.19%。
无线射频识别(RFID)血液冰箱和冷冻柜是指先进的温控储存系统,用于收集和安全保存各种试剂和血液成分,包括血浆衍生物和红血球(RBC)。它们包括互连的管道、毛细管、冷凝器、膨胀器、蒸发器、电动压缩机和有助于调节冰箱温度的恆温器。一些先进的型号还包括配置、压缩机、电动马达和紧急电源系统,以便在波动期间提供能源备份。 RFID 血液冰箱和冷冻机可以即时追踪关键的血小板成分及其状况,并保持产品品质符合食品药物管理局 (FDA) 的规定。除此之外,它们还聪明、安全、可靠,有助于最大限度地减少技术错误并提高营运效率。因此,医院和诊断中心使用 RFID 血液冰箱和冷冻机来储存血液,以进行检测、储存、运输和输血。
推动市场成长的主要因素是白血病、地中海型贫血和血友病等各种慢性疾病的发生率不断上升以及术后失血发生率的上升。同时,医院血库对获取血浆、样本和血小板进行实验和评估细胞功能的需求不断增加,这促进了市场对该产品的需求。此外,配备由耐腐蚀钢和手柄製成的抽屉架的先进血液冰箱和冷冻柜的出现也是另一个促进成长的因素。此类产品包括身份证夹,可以储存过量的血管,并且无需移除整个架子即可取出。此外,政府和非政府组织 (NGO) 不断推出措施和提高意识计划,向大众宣传捐血的好处和误解,这也有利于市场的成长。除此之外,医疗保健基础设施的显着改善、持续的研究和开发(R&D)活动以及持续的产品改进和多样化正在积极刺激市场成长。
本报告也研究了产业竞争格局以及主要参与者的概况,包括 Angelantoni Life Science Srl、Biomed Global、Cardinal Health Inc.、IQM AS、MedSella (MedFlow Clinical Ltd.)、Qingdao Haier Biomedical Co Ltd.、Rollex Group Australia PTY Ltd.、SATO 这些 Corporation Ltd. Venture Research Inc. 请注意,这仅代表部分公司列表,完整列表已在报告中提供。
The global RFID blood refrigerators and freezers market size reached USD 331.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,069.9 Million by 2033, exhibiting a growth rate (CAGR) of 13.19% during 2025-2033.
Radio frequency identification (RFID) blood refrigerators and freezers refer to advanced temperature-controlled storage systems that collect and safely preserve various reagents and blood components, including plasma derivatives and red blood cells (RBCs). They encompass interconnected tubing, a capillary tube, a condenser, expansion, an evaporator, electrically powered compressors, and a thermostat that helps regulate refrigerator temperature. Some advanced models further comprise configurations, compressors, motors, and emergency power systems to provide energy backup during fluctuations. RFID blood refrigerators and freezers allow real-time tracking of critical platelet components and their conditions and maintain the product quality to comply with food and drug administration (FDA) regulations. Apart from this, they are intelligent, safe to use, and reliable and aid in minimizing technical errors and increasing operational efficiency. As a result, RFID blood refrigerators and freezers are used by hospitals and diagnostic centers to store blood for testing, storing, transporting, and transfusion purposes.
The increasing prevalence of various chronic diseases, including leukemia, thalassemia, and hemophilia, and the rising incidences of blood loss post-surgical procedures are primarily driving the market growth. In line with this, the escalating need for blood banks in hospital settings to obtain plasma, samples, and platelets for conducting experiments and assessing cell functions is facilitating the product demand in the market. Additionally, the advent of advanced blood refrigerators and freezers with drawer racks composed of corrosion-resistant steel and handles is acting as another growth-inducing factor. Such products consist of identification cardholders, and they enable the storage of blood tubes in excessive amounts and their retrieval without the removal of the entire rack. Moreover, increasing initiatives and awareness programs by governments and non-governmental organizations (NGOs) toward educating the masses on the benefits and misconceptions of blood donation are favoring the market growth. Apart from this, significant improvements in the healthcare infrastructure, ongoing research and development (R&D) activities, and continuous product enhancements and diversification are positively stimulating the market growth.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Angelantoni Life Science Srl, Biomed Global, Cardinal Health Inc., IQM AS, MedSella (MedFlow Clinical Ltd.), Qingdao Haier Biomedical Co Ltd., Rollex Group Australia PTY Ltd., SATO Vicinity Pty Ltd. (SATO Holdings Corporation), Spacecode Technologies, Terso Solutions Inc. (Promega Corporation), Thalheimer Kuhlung GmbH & Co KG and Venture Research Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.